Programs

Information on Programs undertaken by AMED can be found here

What's New

05/31/24
Terminated Projects - International Collaborative Research Program: Science and Technology Research Partnership for Sustainable Development (SATREPS)
05/09/22
International Collaborative Research Program for Tackling the NTDs (Neglected Tropical Diseases) Challenges in African countries _terminated project
06/02/21
(Update) Research Projects on COVID-19

Search from the Key Field

Project for Advanced Drug Discovery and Development

This project conducts pharmaceutical R&D taking into account the characteristics and properties of modalities in areas ranging from target identification to clinical research in order to promote the practical application of drugs to address high medical needs.
Project for Medical Device and Healthcare

This project supports R&D of medical devices/systems and healthcare, which integrated AI/IoT technologies, measurement technologies, robotics technologies etc. in, aiming improved diagnosis, treatment and prevention of diseases, and the improved QOL of the elderly.
Project for Regenerative /
Cellular Medicine and Gene Therapies

This project supports basic research on regenerative medicine/cell therapy, non-clinical and clinical research, development of foundational manufacturing technology, research utilizing disease-specific iPSCs, and establishment of necessary foundational structures for research, as well as R&D in the field of gene therapy.
Project for Genome and Health Related Data

Toward realization of personalized medicine, this project promotes the development and utilization of genome data infrastructures and supports R & D that contributes to the prevention, diagnosis, and treatment of diseases based on the relationship between genetic mutations and polymorphism and the development of diseases, from a life-stage perspective.
Project for Basic Medical Research

This project supports basic R&D to better understand various functional aspects of life phenomena such as brain functionality, immunity, and aging, as well as to elucidate disease mechanisms in various diseases. Results will be linked with clinical R&D and other integrated projects, while R&D that incorporates clinical issues will be supported.
Project for Seeds Development and Research Base

This project supports basic research and international joint research to create and develop bases combining different fields, modalities and innovative seeds for creation of new modalities. It also promotes development of systems to discover/transfer seeds and conduct high-quality clinical research & trials, establishment of a base of reverse translational research & empirical research in translational research among support centers and core clinical research hospitals.
CiCLE

This project supports R&D conducted through industry-government-academia collaboration and promotes the development of an environment for collaboration by using government investment to create innovative drugs and medical devices, etc.
Moonshot Research and Development Program & Alliance program for Innovative Medical/healthcare research by Government-Academia-Industry Collaboration

Moonshot Research and Development Program aims to create disruptive innovations from Japan and promotes challenging R&D based on revolutionary concepts that are not simply the extension of existing technologies. Alliance program for Innovative Medical/healthcare research by Government-Academia-INdustry collaboration" (Abbreviated name: AIMGAIN) promotes R&D for innovative pharmaceuticals and medical devices etc. through government-industry-academia collaborations.
Programs relating to the Strategy for Strengthening the Vaccine Development and Production System (SCARDA-related and other programs)

Pursuant to the Strategy for Strengthening the Vaccine Development and Production System (the “Vaccine Strategy”), AMED aims to prepare for infectious disease emergencies and be able to respond to more virulent mutant strains and infectious diseases that could prove to be a threat in the future. Accordingly, AMED boosts the funding capacity for strategically significant research, initiative for world-leading vaccine research and development centers, and promotes the strengthening of the pharmaceutical startup ecosystem.

Business division introduction

Grants/Funding information

This website uses cookies to provide you with a better service.
By closing this message or just continuing to browse the site, you are agreeing to our use of cookies. Please see our Privacy Policy for details.

Close